However, the condition to up-regulate FTMT is milder than the one necessary to induce FXN, thus, we proposed to take in consideration an epigenetic therapy in FRDA patients to increase at least FTMT expression, since it could be useful to help protecting these patients from mitochondrial oxidative stress. This evidence concerns the gene FTMT and Friedreich ataxia.